Arcus Biosciences (RCUS) Amortizatization of Intangibles (2017 - 2026)

Arcus Biosciences' Amortizatization of Intangibles history runs 10 years deep, the most recent figure standing at $3.0 million for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 25.0% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $12.0 million (down 47.83% YoY), while the FY2025 annual figure was $13.0 million, down 48.0% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $3.0 million, roughly flat from $3.0 million in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $7.0 million in Q2 2024, with the low at -$2.0 million in Q1 2022.
• The 5-year median for Amortizatization of Intangibles is $4.0 million (2023), against an average of $4.0 million.
• The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles tumbled 295.26% in 2022, then soared 300.0% in 2023.
• Arcus Biosciences' Amortizatization of Intangibles stood at $2.0 million in 2022, then surged by 200.0% to $6.0 million in 2023, then changed by 0.0% to $6.0 million in 2024, then slumped by 50.0% to $3.0 million in 2025, then changed by 0.0% to $3.0 million in 2026.
• Business Quant data shows RCUS's Amortizatization of Intangibles at $3.0 million in Q1 2026, $3.0 million in Q4 2025, and $3.0 million in Q3 2025.